Menarini Group Revenue and Competitors
Estimated Revenue & Valuation
- Menarini Group's estimated annual revenue is currently $2.6B per year.
- Menarini Group's estimated revenue per employee is $201,000
Employee Data
- Menarini Group has 12694 Employees.
- Menarini Group grew their employee count by 7% last year.
Menarini Group's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Brand Manager | Reveal Email/Phone |
2 | Senior Business Manager - Rare Diseases | Reveal Email/Phone |
3 | General Manager | Reveal Email/Phone |
4 | Account Manager / Economist | Reveal Email/Phone |
5 | Representante visitador médico | Reveal Email/Phone |
6 | (Sr Dir) Global Real World Evidence & Epidemiology Lead | Reveal Email/Phone |
7 | Responsabile di Produzione | Reveal Email/Phone |
Menarini Group Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Menarini Group?
Manufacturing Biotechnology Center for the production of recombinant protein in Mammalian, Microrganism and yeast cells
keywords:N/AN/A
Total Funding
12694
Number of Employees
$2.6B
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Menarini Group News
... Bio-Rad Laboratories Inc., Danaher Corporation, Menarini Group, F. Hoffmann-La Roche Ltd., Tosoh Corporation, Siemens Healthcare.
... Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation.
Menarini Group; Auxilium Pharmaceuticals; Endo International; JW Pharmaceutical. This record is divided into numerous distinct regions, one of...
POMEZIA, Italy, June 1, 2021 /PRNewswire/ -- The Menarini Group announced today that additional data have been generated on SEL24/MEN1703, a first-in-class, orally available, dual PIM/FLT3 inhibitor, as part of the DIAMOND-01 trial. The results will be presented at both the upcoming American S ...
Watchword: getting the younger generations talking about art. Following on from the success of the Menarini Pills of Art, with 18 million views worldwide, Menarini now launches the "junior" version, in which young art experts reply to the questions, and sometimes unexpected curiosities, childr ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5011.1M | 13257 | 7% | N/A |
#2 | $2753.9M | 13566 | 2% | N/A |
#3 | $5263.3M | 13632 | 18% | N/A |
#4 | $1930M | 13729 | N/A | N/A |
#5 | $5221.3M | 13813 | 9% | N/A |